” Global CAR T Cell Therapy Market and Clinical Trials Insight 2024″ Report Highlights:
-
CAR T-Cell Therapies Delivery Pipeline and Mechanism of Action
-
Sales Analysis of CAR – T Cell Therapy
-
CAR – T Cell Therapy Market Opportunity: US$ 700 Million
-
CAR-T Cell Therapies Clinical Pipeline by Company, Indication and Phase: 236 Therapies
-
CAR-T Cell Therapies in Highest Phase: Preclinical
-
Marketed CAR-T Cell Therapies: 2 ( Yescarta and Kymriah)
-
Global Market Scenario of CAR T Cell Therapy
-
Global CAR T Cell Therapy Market Future Prospect
Download Report: https://www.kuickresearch.com/report-global-car-t-cell-therapy-market-opportunity-and-clinical-pipeline-insight-2024.php
1. Chimeric Antigen Receptor (CAR) T Cell Therapy – Next Era in Immuno Oncology
1.1 Overview
1.2 History and Development of CAR-T Technology
2. Development of Chimeric Antigen Receptor (CAR) T-Cell Design
2.1 Structure of CAR-T Cell
2.2 1st Generation Chimeric Antigen Receptor
2.3 2nd and 3nd Generation CAR-T Cell
3. Chimeric Antigen Receptor Design Standards
3.1 CAR Modified T-Cells: Targeting
3.2 CAR Modified T-Cell: Signaling
4. CAR T-Cell Therapies Delivery Pipeline and Mechanism of Action
4.1 Process of CAR T-Cell Therapy
4.2 Mechanism of Action
5. Approaches to Improve the Efficacy of CAR-T Cell Therapy
5.1 Introduction
5.2 Targeting the Tumor Stroma with CAR-T Cells
5.3 Targeting the Cytokine Networks
5.4 Combination Strategies for CAR-T Cells
5.5 Targeting the Immune Checkpoints
6. Global CAR T-Cell Therapy – Clinical Trials for Cancer Treatment
6.1 Acute Lymphoblastic Leukemia
6.2 Multiple Myeloma
6.3 Brain Tumors
6.4 Lymphoma
6.5 Solid Tumors
7. CAR-T Cell Therapy Market Analysis by Product
7.1 Kymriah by Novartis
7.2 Yescarta by Gilead
8. Recent Advances Impacting the CAR – T Cell Market
9. Sales Analyis of CAR – T Cell Therapy
10. Cost Analysis and Market Potential of CAR – T Cell Therapy
10.1 Manufacturing Cost Analysis of CAR-T Cell Therapy Products
10.2 Price Analysis of CAR-T Cell Therapy
10.3 Global – Estimated Potential Customer Base and Revenue Analysis
11. Global CAR T-Cell Therapy Market Overview
11.1 Market Share of Cancer Immunotherapy by Technique
11.2 CAR-T Cell Therapy Market Value
12. Global CAR-T Cell Therapy Market Dynamics
12.1 Favorable Parameters
12.2 Challenges
13. Global CAR-T Cell Therapy Market Future Outlook
14. Global CAR-T Cell Therapies Clinical Pipeline by Company, Indication and Phase
14.1 Research
14.2 Preclinical
14.3 Clinical
14.4 Phase-I
14.5 Phase-I/II
14.6 Phase-II
15. Marketed CAR-T Cell Therapies Clinical Insight
15.1 Axicabtagene Ciloleucel (Yescarta)
15.2 Tisagenlecleucel (Kymriah)
16. Competitive Landscape
16.1 Autolus
16.2 Bellicum
16.3 Bluebird
16.4 Celgene
16.5 Cellectis
16.6 Celyad
16.7 Eureka Therapeutics
16.8 Fortress Biotech
16.9 Immune Therapeutics
16.10 Juno Therapeutics
16.11 Kite Pharma
16.12 Novartis
16.13 Sorrento therapeutics
16.14 TILT Biotherapeutics
16.15 Ziopharm
Contact:
Neeraj Chawla
neeraj@kuickresearch.com
+91-11-47067990
